Concepedia

Nicolas Solban

NS

20

Publications

1.5K

Citations

18

H-Index

2000

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Centre Hospitalier de l’Université de Montréal

Acceleron Pharma (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Nicolas Solban is an author at Harvard University specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2000–2024

20

Publications

20

Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth

Roselyne Castonguay, Eric D. Werner, Robert G. Matthews et al. · Journal of Biological Chemistry · 2011 · 219 citations · Full text

, , +17

<b> <i>In Vivo</i> </b> Flow Cytometry

Irene Georgakoudi, Nicolas Solban, John Novak et al. · Cancer Research · 2004 · 193 citations

ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth

Dianne Mitchell, Eileen G. Pobre, Aaron W. Mulivor et al. · Molecular Cancer Therapeutics · 2010 · 151 citations · Full text

Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease

Pelin Özlem Şimşek‐Kiper, Hiroaki Saito, Francesca Gori et al. · New England Journal of Medicine · 2016 · 144 citations · Full text

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines

Jonathan P. Celli, Nicolas Solban, Alvin Liang et al. · Lasers in Surgery and Medicine · 2011 · 108 citations · Full text

Rows per page

1–5 of 20